Barclays’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
Other funds holding TYRA
SL
Barclays's TYRA Position: Q3 2026 in Review
Barclays increased its Tyra Biosciences (TYRA) stake by 23% in Q3 2026, buying an estimated $126K and bringing the position to 24,841 shares worth $543K. The position accounts for ﹤0.01% of the portfolio, ranked #3409.
Barclays first reported a position in TYRA in Q1 2022 and has held it in 19 quarters since. The position peaked at $31.9M in Q1 2026. 155 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.
- Barclays held 24,841 shares of Tyra Biosciences worth $543K as of Q3 2026.
- Barclays bought 4,566 Tyra Biosciences shares in Q3 2026, an estimated $126K.
- Tyra Biosciences made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3409 holding.
- Barclays first reported a position in Tyra Biosciences in Q1 2022 and has held it in 19 quarters since.
- Barclays's Tyra Biosciences position peaked at $31.9M in Q1 2026.
- 155 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.